Literature DB >> 17235569

Extrauterine endometrial stromal sarcoma with JAZF1/JJAZ1 fusion confirmed by RT-PCR and interphase FISH presenting as an inguinal tumor.

Katsuaki Sato1, Yoshimichi Ueda, Junichi Sugaya, Mamoru Ozaki, Masanori Hisaoka, Shogo Katsuda.   

Abstract

Endometrial stromal sarcomas are rare malignant mesenchymal tumors that usually develop in the uterine corpus and occasionally arise at various extrauterine sites. This report describes the first case of primary extrauterine endometrial stromal sarcoma arising in the extraperitoneal portion of the round ligament presenting as a solitary inguinal mass in a 46-year-old woman. The patient presented gradually growing tumor in the right inguinal region. Local tumor resection was performed and no recurrence or metastasis was found at 15 months after the operation. Histological examination revealed that the tumor comprised uniform, spindle-shaped cells with blunt nuclear figure and scattered small arteries, and infiltrated into adjacent tissue. No endometriosis was morphologically identified in the lesion. Immunohistochemically, the tumor cells were positive for CD10, estrogen receptor, progesterone receptor, alpha-smooth muscle actin, and calponin. We confirmed JAZF1/JJAZ1 fusion by reverse transcription-polymerase chain reaction and the corresponding chromosomal translocation by interphase fluorescence in situ hybridization on paraffin sections. It is essential that the inguinal region should be recognized as a possible primary site of endometrial stromal sarcoma, and the detection of a JAZF1/JJAZ1 fusion can be useful when the diagnosis is not confirmed by microscopic observation or immunohistochemistry for the tumor arising in extrauterine sites.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17235569     DOI: 10.1007/s00428-006-0345-8

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  12 in total

1.  Consistent rearrangement of chromosomal band 6p21 with generation of fusion genes JAZF1/PHF1 and EPC1/PHF1 in endometrial stromal sarcoma.

Authors:  Francesca Micci; Ioannis Panagopoulos; Bodil Bjerkehagen; Sverre Heim
Journal:  Cancer Res       Date:  2006-01-01       Impact factor: 12.701

Review 2.  JAZF1/JJAZ1 gene fusion in endometrial stromal sarcomas: molecular analysis by reverse transcriptase-polymerase chain reaction optimized for paraffin-embedded tissue.

Authors:  Andelko Hrzenjak; Farid Moinfar; Fattaneh A Tavassoli; Bettina Strohmeier; Marie-Luise Kremser; Kurt Zatloukal; Helmut Denk
Journal:  J Mol Diagn       Date:  2005-08       Impact factor: 5.568

3.  The round ligament: a target organ for steroid hormones.

Authors:  P Smith; G Heimer; A Norgren; U Ulmsten
Journal:  Gynecol Endocrinol       Date:  1993-06       Impact factor: 2.260

4.  Inguinal endometriosis: pathogenetic and clinical implications.

Authors:  G B Candiani; P Vercellini; L Fedele; N Vendola; S Carinelli; V Scaglione
Journal:  Obstet Gynecol       Date:  1991-08       Impact factor: 7.661

5.  Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumors.

Authors:  J I Koontz; A L Soreng; M Nucci; F C Kuo; P Pauwels; H van Den Berghe; P Dal Cin; J A Fletcher; J Sklar
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-22       Impact factor: 11.205

6.  Endometrial stromal sarcoma of the vulva arising in extraovarian endometriosis: a case report and literature review.

Authors:  W Irvin; T Pelkey; L Rice; W Andersen
Journal:  Gynecol Oncol       Date:  1998-11       Impact factor: 5.482

7.  Primary pulmonary synovial sarcoma: a clinicopathologic, immunohistochemical, and molecular study of 11 cases.

Authors:  Sumika Okamoto; Masanori Hisaoka; Tsutomu Daa; Kinta Hatakeyama; Teruo Iwamasa; Hiroshi Hashimoto
Journal:  Hum Pathol       Date:  2004-07       Impact factor: 3.466

8.  Cytogenetic and molecular genetic analyses of endometrial stromal sarcoma: nonrandom involvement of chromosome arms 6p and 7p and confirmation of JAZF1/JJAZ1 gene fusion in t(7;17).

Authors:  Francesca Micci; Claudia U Walter; Manuel R Teixeira; Ioannis Panagopoulos; Bodil Bjerkehagen; Gunnar Saeter; Sverre Heim
Journal:  Cancer Genet Cytogenet       Date:  2003-07-15

Review 9.  Primary extrauterine endometrial stromal neoplasms: a clinicopathologic study of 20 cases and a review of the literature.

Authors:  K L Chang; G S Crabtree; S K Lim-Tan; R L Kempson; M R Hendrickson
Journal:  Int J Gynecol Pathol       Date:  1993-10       Impact factor: 2.762

10.  Molecular detection of JAZF1-JJAZ1 gene fusion in endometrial stromal neoplasms with classic and variant histology: evidence for genetic heterogeneity.

Authors:  Hsuan-Ying Huang; Marc Ladanyi; Robert A Soslow
Journal:  Am J Surg Pathol       Date:  2004-02       Impact factor: 6.394

View more
  5 in total

1.  The utility of the 3D imaging software in the macroscopic rendering of complex gynecologic specimens.

Authors:  Luca Roncati; Beniamino Palmieri; Teresa Pusiol; Francesco Piscioli; Michele Scialpi; Giuseppe Barbolini; Antonio Maiorana
Journal:  J Gynecol Oncol       Date:  2015-04       Impact factor: 4.401

2.  Type 2 NF1 deletions are highly unusual by virtue of the absence of nonallelic homologous recombination hotspots and an apparent preference for female mitotic recombination.

Authors:  Katharina Steinmann; David N Cooper; Lan Kluwe; Nadia A Chuzhanova; Cornelia Senger; Eduard Serra; Conxi Lazaro; Montserrat Gilaberte; Katharina Wimmer; Viktor-Felix Mautner; Hildegard Kehrer-Sawatzki
Journal:  Am J Hum Genet       Date:  2007-10-31       Impact factor: 11.025

Review 3.  JAZF1/SUZ12 gene fusion in endometrial stromal sarcomas.

Authors:  Andelko Hrzenjak
Journal:  Orphanet J Rare Dis       Date:  2016-02-16       Impact factor: 4.123

4.  Immunohistochemical and Molecular Characterization of Endometrial Stromal Sarcomas.

Authors:  Sneha Subbaraya; Sudha S Murthy; Sandhya Devi G
Journal:  Clin Pathol       Date:  2020-05-11

Review 5.  Molecular pathogenesis and prognostication of "low-grade'' and "high-grade" endometrial stromal sarcoma.

Authors:  Francesca Micci; Sverre Heim; Ioannis Panagopoulos
Journal:  Genes Chromosomes Cancer       Date:  2020-11-10       Impact factor: 5.006

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.